Alliance Pharma plc (AIM:APH)
London
· Delayed Price · Currency is GBP · Price in GBX 64.60
+0.20 (0.31%)
Apr 25, 2025, 5:15 PM GMT+1
Alliance Pharma Revenue
In the year 2024, Alliance Pharma had annual revenue of 178.84M GBP, down -1.02%. Alliance Pharma had revenue of 94.97M in the half year ending December 31, 2024, with 7.13% growth.
Revenue
178.84M
Revenue Growth
-1.02%
P/S Ratio
1.96
Revenue / Employee
616.68K
Employees
290
Market Cap
349.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 178.84M | -1.84M | -1.02% |
| Dec 31, 2023 | 180.68M | 13.26M | 7.92% |
| Dec 31, 2022 | 167.42M | 4.21M | 2.58% |
| Dec 31, 2021 | 163.21M | 33.41M | 25.74% |
| Dec 31, 2020 | 129.80M | -5.84M | -4.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Alliance Pharma News
- 6 weeks ago - Alliance Pharma agrees £362m takeover by biggest shareholder - Evening Standard
- 3 months ago - Alliance Pharma to accept £349.7m buyout offer from biggest investor - Evening Standard
- 7 months ago - Alliance Pharma PLC (FRA:DVL) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ... - GuruFocus
- 7 months ago - Half Year 2024 Alliance Pharma PLC Earnings Call Transcript - GuruFocus